KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BLPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Bellerophon Therapeutics stock upgraded from Sell Candidate to Buy Candidate after Friday trading session.
(Updated on Apr 26, 2024)

Buy candidate since Apr 26, 2024 PDF

The Bellerophon Therapeutics stock price gained 0.727% on the last trading day (Friday, 26th Apr 2024), rising from $0.0550 to $0.0554. During the last trading day the stock fluctuated 8.98% from a day low at $0.0551 to a day high of $0.0601. The price has risen in 5 of the last 10 days and is up by 0.73% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 18 thousand shares were bought and sold for approximately $970.11 .

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Bellerophon Therapeutics stock with a 90% probability to be traded between $0.0482 and $0.0627 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BLPH Signals & Forecast

The Bellerophon Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.0551 and $0.0551. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, April 24, 2024, and so far it has risen 2.40%. Further rise is indicated until a new top pivot has been found. Bellerophon Therapeutics has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Friday, March 15, 2024 with a target of $0.0520. Despite whether the objective of the signal formation has been reached the stock may continue to perform well.

Support, Risk & Stop-loss for Bellerophon Therapeutics stock

Bellerophon Therapeutics finds support from accumulated volume at $0.0550 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0050 between high and low, or 8.98%. For the last week, the stock has had daily average volatility of 7.05%.

Our recommended stop-loss: $0.0526 (-5.07%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (BLPH) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Bellerophon Therapeutics to open at $0.0569, and during the day (based on 14 day Average True Range), to move between $0.0504 and $0.0604, which gives a possible trading interval of +/-$0.0050 (+/-9.03%) up or down from last closing price. If Bellerophon Therapeutics takes out the full calculated possible swing range there will be an estimated 18.07% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0550 (0.72%) than the resistance at $0.0570 (2.89%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bellerophon Therapeutics stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Bellerophon Therapeutics stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.621 Buy Candidate Upgraded

Predicted Opening Price for Bellerophon Therapeutics of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$0.0569 ( 2.62%) $0.0554

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BLPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0618 11.55 %
R2 0.0599 8.14 %
R1 0.0587 6.03 %
Current price: 0.0554
Support S1 0.0550 -0.796 %
S2 0.0538 -2.90 %
S3 0.0519 -6.32 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0640 15.52 %
R2 0.0571 2.98 %
R1 0.0570 2.89 %
Current price 0.0554
Support S1 0.0550 -0.722%
S2 0.0533 -3.88%
S3 0.0510 -7.94%

FAQ

What is the symbol for Bellerophon Therapeutics Stock and on which exchange is it traded?
The symbol for Bellerophon Therapeutics is BLPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bellerophon Therapeutics Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Bellerophon Therapeutics stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Bellerophon Therapeutics Stock?
Bellerophon Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bellerophon Therapeutics Stock.

What's the current price of Bellerophon Therapeutics Stock?
As of the end of day on the Apr 26, 2024, the price of an Bellerophon Therapeutics (BLPH) share was $0.0554.

What is the 52-week high and low for Bellerophon Therapeutics Stock?
The 52-week high for Bellerophon Therapeutics Stock is $11.15 and the 52-week low is $0.0290.

What is the market capitalization of Bellerophon Therapeutics Stock?
As of the Apr 26, 2024, the market capitalization of Bellerophon Therapeutics is 677.686K.

When is the next earnings date for Bellerophon Therapeutics?
The upcoming earnings date for Bellerophon Therapeutics is Jun 06, 2024.
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT